Publikationen in Zusammenarbeit mit Forschern von Clínica Universitaria de Navarra (49)

2024

  1. Accidental intravenous probiotic injection in an immunocompromised patient: Implications and consequences

    Enfermedades Infecciosas y Microbiologia Clinica

  2. How can we optimize the diagnostic and therapeutic approach of pneumonia? Expert opinion-based recommendations

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 42, Núm. 8, pp. 442-452

  3. Impact of Catheter-Drawn Blood Cultures on Patient Management: A Multicenter, Retrospective Cohort Study

    Open Forum Infectious Diseases, Vol. 11, Núm. 7

  4. One-Stage Versus Two-Stage Revision Surgery for Periprosthetic Hip Infection: An Updated Systematic Review and Meta-Analysis of Clinical Outcomes

    Journal of the American Academy of Orthopaedic Surgeons

  5. Pseudomonas aeruginosa Bloodstream Infections Presenting with Septic Shock in Neutropenic Cancer Patients: Impact of Empirical Antibiotic Therapy

    Microorganisms, Vol. 12, Núm. 4

  6. Risk factors and clinical impact of multidrug resistance in healthcare-associated bacteraemic urinary tract infections: a post-hoc analysis of a multicentre prospective cohort in Spain

    Journal of Hospital Infection, Vol. 151, pp. 173-185

  7. Vascular catheter-related infections: an endemic disease in healthcare institutions. An opinion paper of the Spanish Society of Cardiovascular Infections (SEICAV)

    Revista Espanola de Quimioterapia, Vol. 37, Núm. 5, pp. 387-400

2023

  1. Disseminated lymphadenopathy during chemotherapy for squamous cell lung carcinoma

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 7, pp. 438-440

  2. Significant increase of CTX-M-15-ST131 and emergence of CTX-M-27-ST131 Escherichia coli high-risk clones causing healthcare-associated bacteraemia of urinary origin in Spain (ITUBRAS-2 project)

    The Journal of antimicrobial chemotherapy, Vol. 78, Núm. 9, pp. 2291-2296

2022

  1. Data on the effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with mild COVID-19.

    CORA.Repositori de Dades de Recerca

  2. Dysautonomia in COVID-19 Patients: A Narrative Review on Clinical Course, Diagnostic and Therapeutic Strategies

    Frontiers in Neurology, Vol. 13

  3. Effect of Combination Antibiotic Empirical Therapy on Mortality in Neutropenic Cancer Patients with Pseudomonas aeruginosa Pneumonia

    Microorganisms, Vol. 10, Núm. 4

  4. Pseudomonas aeruginosa Bloodstream Infections in Patients with Cancer: Differences between Patients with Hematological Malignancies and Solid Tumors

    Pathogens, Vol. 11, Núm. 10

2021

  1. Executive summary of the Consensus Document of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and of the Spanish Association of Surgeons (AEC) in antibiotic prophylaxis in surgery

    Cirugia Espanola, Vol. 99, Núm. 1, pp. 11-26

  2. In vitro activity of imipenem/relebactam against Gram-negative clinical isolates in two Spanish tertiary hospitals

    Revista Espanola de Quimioterapia, Vol. 34, Núm. 6, pp. 668-671

2020

  1. Clinical predictive model of multidrug resistance in neutropenic cancer patients with bloodstream infection due to Pseudomonas aeruginosa

    Antimicrobial Agents and Chemotherapy, Vol. 64, Núm. 4

  2. Histopathological findings in fatal COVID-19 severe acute respiratory syndrome: Preliminary experience from a series of 10 Spanish patients

    Thorax, Vol. 75, Núm. 12, pp. 1116-1118

  3. SARS-CoV-2 infection with associated rhabdomyolysis and probable myocarditis

    European Journal of Case Reports in Internal Medicine, Vol. 7, Núm. 9

  4. Suppressive antibiotic therapy in prosthetic joint infections: a multicentre cohort study

    Clinical Microbiology and Infection, Vol. 26, Núm. 4, pp. 499-505

2019

  1. Efficacy and safety of long-term use of tedizolid after liver transplantation in an adolescent with pulmonary tuberculosis

    Journal of Antimicrobial Chemotherapy